A Phase 1 Study Evaluating Safety and Efficacy of Parsaclisib in Combination with Bendamustine + Obinutuzumab in Patients with Relapsed or Refractory Follicular Lymphoma (R/R FL) (CITADEL-102)

Authors :: Mehdi Hamadani
Morton Coleman
Ralph Boccia
Juraj Duras
Martin Hutchings
Pier Luigi Zinzani
Raul Cordoba
Mariana Bastos Oreiro
Wei Jiang
Michael Stouffs
Peter Langmuir
Juan-Manuel Sancho
Source :: Transplantation and Cellular Therapy. 28:S407-S408
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Subjects :: Transplantation
Molecular Medicine
Immunology and Allergy
Cell Biology
Hematology

Full Text Access

Tools